In conclusion , intravenous administration of COMPOUND_XXX at doses of 0.3 , 1.0 and 3 mg / kg for 13 weeks using a once weekly dosing schedule was associated with compound - related decreases in body weight parameters , food consumption , white blood cell counts and lymphocyte counts at doses ≥ 0.3 mg / kg .
In conclusion , intravenous administration of COMPOUND_XXX at doses of 0.3 , 1.0 and 3 mg / kg for 13 weeks using a once weekly dosing schedule was associated with compound - related decreases in body weight parameters , food consumption , white blood cell counts and lymphocyte counts at doses ≥ 0.3 mg / kg .
O O O O O O O O O O B-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE I-DOSE O O O O O O O O O O O O O O O B-MANIFESTATION_FINDING O B-STUDY_TESTCD I-STUDY_TESTCD O O B-STUDY_TESTCD I-STUDY_TESTCD O B-STUDY_TESTCD I-STUDY_TESTCD I-STUDY_TESTCD I-STUDY_TESTCD O B-STUDY_TESTCD I-STUDY_TESTCD O O O B-DOSE I-DOSE I-DOSE I-DOSE O